Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Slevin

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
British Journal of Cancer|March 1, 1993
Patient compliance with prolonged low-dose oral etoposide for small cell lung cancerC R Lee, P W Nicholson, R L Souhami, et al.
British Journal of Cancer|July 17, 1999
An analysis of first-time enquirers to the CancerBACUP information service: variations with cancer site, demographic status and geographical locationM Boudioni, K McPherson, J Mossman, et al.
British Journal of Cancer|December 1, 1990
Phase II trial of UFT in advanced colorectal and gastric cancerS T Malik, D Talbot, P I Clarke, et al.
BMJ (Clinical Research Ed.)|January 4, 1992
Appropriate chemotherapy for palliating advanced cancerR D Rubens, K E Towlson, A J Ramirez, et al.
Nuclear Medicine Communications|March 1, 1989
Therapeutic considerations in the use of intraperitoneal radiolabelled monoclonal antibodies in ovarian carcinomaM E Crowther, B G Ward, M Granowska, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observationM L Slevin, S P Joel, R Whomsley, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Double modulation of 5-fluorouracil with interferon alpha-2a and high-dose leucovorin in advanced neuroendocrine tumoursD Papamichael, M T Seymour, R T Penson, et al.
BMJ (Clinical Research Ed.)|June 2, 1990
Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general publicM L Slevin, L Stubbs, H J Plant, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1988
Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphyM Granowska, C C Nimmon, K E Britton, et al.
British Journal of Cancer|January 1, 1988
Tamoxifen in refractory ovarian cancer: the use of a loading dose scheduleR J Osborne, S T Malik, M L Slevin, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
British Journal of Cancer|March 1, 1993
Patient compliance with prolonged low-dose oral etoposide for small cell lung cancerC R Lee, P W Nicholson, R L Souhami, et al.
British Journal of Cancer|July 17, 1999
An analysis of first-time enquirers to the CancerBACUP information service: variations with cancer site, demographic status and geographical locationM Boudioni, K McPherson, J Mossman, et al.
British Journal of Cancer|December 1, 1990
Phase II trial of UFT in advanced colorectal and gastric cancerS T Malik, D Talbot, P I Clarke, et al.
BMJ (Clinical Research Ed.)|January 4, 1992
Appropriate chemotherapy for palliating advanced cancerR D Rubens, K E Towlson, A J Ramirez, et al.
Nuclear Medicine Communications|March 1, 1989
Therapeutic considerations in the use of intraperitoneal radiolabelled monoclonal antibodies in ovarian carcinomaM E Crowther, B G Ward, M Granowska, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observationM L Slevin, S P Joel, R Whomsley, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Double modulation of 5-fluorouracil with interferon alpha-2a and high-dose leucovorin in advanced neuroendocrine tumoursD Papamichael, M T Seymour, R T Penson, et al.
BMJ (Clinical Research Ed.)|June 2, 1990
Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general publicM L Slevin, L Stubbs, H J Plant, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1988
Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphyM Granowska, C C Nimmon, K E Britton, et al.
British Journal of Cancer|January 1, 1988
Tamoxifen in refractory ovarian cancer: the use of a loading dose scheduleR J Osborne, S T Malik, M L Slevin, et al.
Pageof 14